PROQR THERAPEUTICS EO-04 (0PQ) — Capital Reinvestment Ratio
PROQR THERAPEUTICS EO-04 (0PQ) has a Capital Reinvestment Ratio of 0.06x as of December 2023, meaning it reinvests 0% of its operating cash flow (€21.55 Million) in capital expenditures (€1.37 Million). Check PROQR THERAPEUTICS EO-04 (0PQ) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PROQR THERAPEUTICS EO-04 Capital Reinvestment Ratio (2023–2023)
This chart tracks PROQR THERAPEUTICS EO-04's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see 0PQ cash flow conversion.
Annual Capital Reinvestment Ratio for PROQR THERAPEUTICS EO-04 (2023–2023)
Year-by-year Capital Reinvestment Ratio for PROQR THERAPEUTICS EO-04 from 2023 to 2023. See 0PQ FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | €21.55 Million | €1.37 Million | — |